Advent is a biotech company applying an AI-powered platform to accelerate AAV capsid discovery for gene therapy. Using proprietary datasets and high-throughput data generation, it develops synthetic capsids optimized for therapeutic delivery. The company builds a pipeline of gene delivery tools targeting applications in precision therapeutics.
Number of investors
11st Round
Dec 3, 2025
Last Round
Dec 3, 2025
| Round | Source | |||||
|---|---|---|---|---|---|---|
| 1 | Dec 3, 2025 | -- | -- | Pro |